Conatus Pharmaceuticals CEO Steven Mento's 2018 pay slips 4% to $1.3M
Conatus Pharmaceuticals reports 2018 executive compensation
By ExecPay News
Published: April 30, 2019
Conatus Pharmaceuticals reported fiscal year 2018 executive compensation information on April 30, 2019.
In 2018, three executives at Conatus Pharmaceuticals received on average a compensation package of $992K, a 38% decrease compared to previous year.
Average pay of disclosed executives at Conatus Pharmaceuticals
Steven J. Mento, Chief Executive Officer, received $1.3M in total, which decreased by 4% compared to 2017. 43% of Mento's compensation, or $537K, was in salary. Mento also received $215K in non-equity incentive plan, $483K in option awards, as well as $17K in other compensation.
Keith W. Marshall, Chief Financial Officer, received a compensation package of $875K, which decreased by 66% compared to previous year. 48% of the compensation package, or $419K, was in salary.
David T. Hagerty, Executive Vice President, Clinical Development, earned $849K in 2018, a 3% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 30, 2019.